Rémi Droller
Director
Mr. Droller has been a director since April 2016. Mr. Droller has been working as Managing Partner with Kurma Partners since 2010 and is in charge of investments in AM Pharma, Orphazyme, Oxthera (Sweden), ImCheck (France), Stat Dx, Zealand Pharma, Vico Therapeutics, Flamingo Therapeutics and Dynacure.
Mr. Droller started at CDC Innovation (now ...
Roles at Pharvaris
Director
Current role
My work style
How I prefer to work
Qualities I value in my colleagues
Sign up to see more about the team at Pharvaris
My pet peeves
My communication style
Org chart
Teams
No teams
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.